In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients

about

Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology

P2860

Q33758620-A190F15D-43CF-4561-8E0A-EB31FC209CFC

P2860

In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients

Item

http://www.wikidata.org/entity/Q35823963

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

In vitro activity of sparfloxa ...... olates from pediatric patients

@ast

In vitro activity of sparfloxa ...... olates from pediatric patients

@en

type

Item

label

In vitro activity of sparfloxa ...... olates from pediatric patients

@ast

In vitro activity of sparfloxa ...... olates from pediatric patients

@en

prefLabel

In vitro activity of sparfloxa ...... olates from pediatric patients

@ast

In vitro activity of sparfloxa ...... olates from pediatric patients

@en

P1476

In vitro activity of sparfloxa ...... olates from pediatric patients

@en

P2093

A G Arguedas

http://www.w3.org/2001/XMLSchema#string

H R Stutman

http://www.w3.org/2001/XMLSchema#string

J C Akaniro

http://www.w3.org/2001/XMLSchema#string

O M Vargas

http://www.w3.org/2001/XMLSchema#string

P2860

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent

In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone

In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy.

Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.

In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum.

Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.

Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae

In-vitro activity of sparfloxacin, a new quinolone antimicrobial agent.

P304

255-261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.36.2.255

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1992-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1318674

http://www.w3.org/2001/XMLSchema#string

P921

quinolone

P932

188342

http://www.w3.org/2001/XMLSchema#string

In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients

about

P2860

P2860

In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932